ScienceDex / Researcher record
Eline Appelmans
- Digital Infuzion, Inc. (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $4,718,200 | 1 | #1,218 |
| 2025 | $4,894,967 | 1 | #1,446 |
| 2026 | $5,061,660 | 1 | #2,788 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20241 record
- FY20251 record
- FY2026 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 79693922Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award records by amount
NIH award records listing Eline Appelmans as a PI. Multi-PI records show the full award amount for context.
- 75N95024D00001-P00005-759502400001-1N01Contact PITASK ORDER 1 - OCR PROJECT MANAGEMENT, DSMB AND CROMS-RELATED SUPPORT$5.1Maward amount
Award organization
Organizations that administered FY2026 awards listing Eline Appelmans as a PI.
FY2026 award administered by Digital Infuzion, Inc. (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardDigital Infuzion, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1218
- 2024Entered Top 25% NationallyRanked #1218
- 2024Entered Top 10% NationallyRanked #1218
- 2025$5M Cumulative Funding
- 2026$10M Cumulative Funding